225 related articles for article (PubMed ID: 17359538)
21. C-terminus of human BKca channel alpha subunit enhances the permeability of the brain endothelial cells by interacting with caveolin-1 and triggering caveolin-1 intracellular trafficking.
Song Y; Wang P; Ma J; Xue Y
Neuromolecular Med; 2014 Jun; 16(2):499-509. PubMed ID: 24705869
[TBL] [Abstract][Full Text] [Related]
22. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of long non-coding RNA MALAT1 increases the blood-tumor barrier permeability by up-regulating miR-140.
Ma J; Wang P; Yao Y; Liu Y; Li Z; Liu X; Li Z; Zhao X; Xi Z; Teng H; Liu J; Xue Y
Biochim Biophys Acta; 2016 Feb; 1859(2):324-38. PubMed ID: 26619802
[TBL] [Abstract][Full Text] [Related]
24. Role of ROS/RhoA/PI3K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase.
Gu YT; Xue YX; Wang YF; Wang JH; ShangGuan QR; Zhang JX; Qin LJ
J Mol Neurosci; 2012 Sep; 48(1):302-12. PubMed ID: 22581438
[TBL] [Abstract][Full Text] [Related]
25. The modulation of protein kinase A and heat shock protein 70 is involved in the reversible increase of blood-brain tumor barrier permeability induced by papaverine.
Wang ZH; Xue YX; Liu YH
Brain Res Bull; 2010 Nov; 83(6):367-73. PubMed ID: 20728510
[TBL] [Abstract][Full Text] [Related]
26. Cerebrovascular vasodilation to extraluminal acidosis occurs via combined activation of ATP-sensitive and Ca2+-activated potassium channels.
Lindauer U; Vogt J; Schuh-Hofer S; Dreier JP; Dirnagl U
J Cereb Blood Flow Metab; 2003 Oct; 23(10):1227-38. PubMed ID: 14526233
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction.
Zhang Z; Xia C; Xue Y; Liu Y
J Neurosci Res; 2009 Aug; 87(10):2282-9. PubMed ID: 19326437
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.
Lockman PR; Mittapalli RK; Taskar KS; Rudraraju V; Gril B; Bohn KA; Adkins CE; Roberts A; Thorsheim HR; Gaasch JA; Huang S; Palmieri D; Steeg PS; Smith QR
Clin Cancer Res; 2010 Dec; 16(23):5664-78. PubMed ID: 20829328
[TBL] [Abstract][Full Text] [Related]
29. Bradykinin increased the permeability of BTB via NOS/NO/ZONAB-mediating down-regulation of claudin-5 and occludin.
Liu LB; Liu XB; Ma J; Liu YH; Li ZQ; Ma T; Zhao XH; Xi Z; Xue YX
Biochem Biophys Res Commun; 2015 Aug; 464(1):118-25. PubMed ID: 26106824
[TBL] [Abstract][Full Text] [Related]
30. Bradykinin-induced blood-tumor barrier opening is mediated by tumor necrosis factor-alpha.
Qin LJ; Gu YT; Zhang H; Xue YX
Neurosci Lett; 2009 Jan; 450(2):172-5. PubMed ID: 18983897
[TBL] [Abstract][Full Text] [Related]
31. Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway.
Liu LB; Xue YX; Liu YH
J Neurooncol; 2010 Sep; 99(2):187-94. PubMed ID: 20146088
[TBL] [Abstract][Full Text] [Related]
32. The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation.
Emerich DF; Dean RL; Osborn C; Bartus RT
Clin Pharmacokinet; 2001; 40(2):105-23. PubMed ID: 11286321
[TBL] [Abstract][Full Text] [Related]
33. Cyclic GMP-specific phosphodiesterase inhibition and intracarotid bradykinin infusion enhances permeability into brain tumors.
Sugita M; Black KL
Cancer Res; 1998 Mar; 58(5):914-20. PubMed ID: 9500450
[TBL] [Abstract][Full Text] [Related]
34. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.
Köhler R; Wulff H; Eichler I; Kneifel M; Neumann D; Knorr A; Grgic I; Kämpfe D; Si H; Wibawa J; Real R; Borner K; Brakemeier S; Orzechowski HD; Reusch HP; Paul M; Chandy KG; Hoyer J
Circulation; 2003 Sep; 108(9):1119-25. PubMed ID: 12939222
[TBL] [Abstract][Full Text] [Related]
35. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
36. Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agents.
Neuwelt EA; Barnett PA; McCormick CI; Remsen LG; Kroll RA; Sexton G
Clin Cancer Res; 1998 Jun; 4(6):1549-55. PubMed ID: 9626476
[TBL] [Abstract][Full Text] [Related]
37. A pharmacologic activator of endothelial KCa channels enhances coronary flow in the hearts of type 2 diabetic rats.
Mishra RC; Wulff H; Cole WC; Braun AP
J Mol Cell Cardiol; 2014 Jul; 72():364-73. PubMed ID: 24787473
[TBL] [Abstract][Full Text] [Related]
38. Bradykinin selectively modulates the blood-tumor barrier via calcium-induced calcium release.
Wang YB; Liu YH
J Neurosci Res; 2009 Feb; 87(3):660-7. PubMed ID: 18831066
[TBL] [Abstract][Full Text] [Related]
39. Krüppel-like factor 4 regulates blood-tumor barrier permeability via ZO-1, occludin and claudin-5.
Ma J; Wang P; Liu Y; Zhao L; Li Z; Xue Y
J Cell Physiol; 2014 Jul; 229(7):916-26. PubMed ID: 24318462
[TBL] [Abstract][Full Text] [Related]
40. Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms.
Rainov NG; Ikeda K; Qureshi NH; Grover S; Herrlinger U; Pechan P; Chiocca EA; Breakefield XO; Barnett FH
Hum Gene Ther; 1999 Jan; 10(2):311-8. PubMed ID: 10022555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
